You are here: Industry Insights > Diabetes

News List

Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical expresspharma
June 11, 2020
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA.
US FDA asks five firms to recall diabetes drug with high NDMA levels expresspharma
May 29, 2020
It named Apotex Corp as one of the firms whose metformin tablets have high levels of NDMA, but did not reveal the other four firms.
Novo Nordisk launches social responsibility strategy for diabetes pharmatimes
May 28, 2020
Novo Nordisk has launch a new social responsibility strategy Defeat Diabetes.
People with diabetes at higher risk of amid pandemic pharmatimes
May 21, 2020
NHS England is calling on people with diabetes to access the help available to them after new research showed that those living with the condition are at significantly higher risk of dying with COVID-19.
Stevanato Group Collaborates with Cambridge Design Partnership contractpharma
April 29, 2020
The companies will develop a pen-injector for patients suffering from diabetes together.
Dapnat launch to boost Natco’s presence in India’s diabetes market but concerted efforts required, s expresspharma
April 29, 2020
Natco is a new player within the cardiovascular and diabetes therapeutic space, launching its Cardiology and Diabetic (CnD) division in early 2017.
Harvard spins out oral biologic tech with a focus on diabetes fiercebiotech
April 13, 2020
A new spinout from Harvard University hopes to one day have people with diabetes reach for a bottle of pills instead of the syringe when they need to take their frequent medications.
Using fatty acids in oral formulations to improve drug delivery europeanpharmaceuticalreview
April 07, 2020
Researchers have used triglyceride fatty acids to develop an oral formulation for drugs that are usually injected or taken intravenously.
Pancreas app now available for type I diabetics in UK pharmatimes
March 17, 2020
The world’s first licensed, downloadable artificial pancreas app for people with type I diabetes has been launched in the UK.
￡12m committed to preventable disease research pharmatimes
March 16, 2020
The National Institute for Health Research (NIHR) has revealed that the UK Government has committed an extra ￡12 million to the organisation in 2020/21 for research into preventable diseases.